Page last updated: 2024-10-24

chloroquine and Eczema, Atopic

chloroquine has been researched along with Eczema, Atopic in 6 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Atopic dermatitis is often associated with increased pain."1.91Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis. ( Akiyama, T; Bystrom, L; Ishida, H; Markan, A; Pavlenko, D; Todurga Seven, Z; Verpile, R, 2023)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Pavlenko, D1
Todurga Seven, Z1
Bystrom, L1
Markan, A1
Verpile, R1
Ishida, H1
Akiyama, T1
Ramachandran, R1
Thompson, SK1
Malkmus, S1
Mieda, T1
Lin, JH1
Gupta, S1
Yaksh, TL1
SIDI, E1
REINBERG, A1
HINCKY, M1
MAKARENKO, II1
LEVITSKII, ER1
Zirwas, MJ1
Döring, HF1
Müllejans-Kreppel, U1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 1, Randomized, Double-Blind, Vehicle-Controlled Ascending Doses Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASN008 Topical Gel in Healthy Volunteers and Subjects With Atopic Dermatitis[NCT03798561]Phase 124 participants (Actual)Interventional2019-01-14Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

6 other studies available for chloroquine and Eczema, Atopic

ArticleYear
Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis.
    Acta dermato-venereologica, 2023, 08-22, Volume: 103

    Topics: Animals; Calcium; Capsaicin; Chloroquine; Dermatitis, Atopic; Disease Models, Animal; Histamine; Neu

2023
Topical Application of ASN008, a Permanently Charged Sodium Channel Blocker, Shows Robust Efficacy, a Rapid Onset, and Long Duration of Action in a Mouse Model of Pruritus.
    The Journal of pharmacology and experimental therapeutics, 2020, Volume: 374, Issue:3

    Topics: Administration, Topical; Animals; Antipruritics; Chloroquine; Dermatitis, Atopic; Disease Models, An

2020
[Treatment of cutaneous allergy with synthetic antimalarials (chronic obstinate urticaria)].
    La Semaine des hopitaux: therapeutique, 1961, Volume: 37

    Topics: Antimalarials; Chloroquine; Chronic Disease; Dermatitis, Atopic; Humans; Urticaria

1961
[RESOCHIN IN CLINICAL INTERNAL MEDICINE AND ITS POSSIBLE SIDE EFFECTS].
    Sovetskaia meditsina, 1964, Volume: 27

    Topics: Acute Kidney Injury; Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Collagen Diseases

1964
Dramatic response to chloroquine and mirtazapine for recalcitrant atopic dermatitis.
    Dermatitis : contact, atopic, occupational, drug, 2006, Volume: 17, Issue:4

    Topics: Adolescent; Antimalarials; Chloroquine; Dermatitis, Atopic; Drug Therapy, Combination; Histamine H1

2006
[Chloroquine--therapy of atopic dermatitis].
    Zeitschrift fur Hautkrankheiten, 1987, Aug-15, Volume: 62, Issue:16

    Topics: Adolescent; Adult; Aged; Chloroquine; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Adm

1987